Evidence map›Paper›PMID 24386297›Full record

ArticlePloS one2013

A Mason-Pfizer Monkey virus Gag-GFP fusion vector allows visualization of capsid transport in live cells and demonstrates a role for microtubules.

Jasmine Clark, Petra Grznarova, Elizabeth Stansell, William Diehl, Jan Lipov, Paul Spearman, Tomas Ruml, Eric Hunter

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Retroviruses use different IPNature communications · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Jasmine ClarkEmory Vaccine Center at the Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
Petra GrznarovaDepartment of Biochemistry and Microbiology, Institute of Chemical Technology, Prague, Czech Republic.
Elizabeth StansellEmory Vaccine Center at the Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
William DiehlEmory Vaccine Center at the Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America.
Jan LipovDepartment of Biochemistry and Microbiology, Institute of Chemical Technology, Prague, Czech Republic.
Paul SpearmanDepartment of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Tomas RumlDepartment of Biochemistry and Microbiology, Institute of Chemical Technology, Prague, Czech Republic.
Eric HunterEmory Vaccine Center at the Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, United States of America ; Department of Pathology, Emory University, Atlanta, Georgia, United States of America.
Emory University · USUniversity of Chemistry and Technology, Prague · CZ

Funding

GENETICS OF PRIMATE D TYPE RETROVIRUSESR01CA027834 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HUNTER, ERIC · 1985 to 2011
$3.6M
NCI NIH HHS R01 CA027834NCI NIH HHS R01-CA-27834
6 · The paper itself

Abstract

Immature capsids of the Betaretrovirus, Mason-Pfizer Monkey virus (M-PMV), are assembled in the pericentriolar region of the cell, and are then transported to the plasma membrane for budding. Although several studies, utilizing mutagenesis, biochemistry, and immunofluorescence, have defined the role of some viral and host cells factors involved in these processes, they have the disadvantage of population analysis, rather than analyzing individual capsid movement in real time. In this study, we created an M-PMV vector in which the enhanced green fluorescent protein, eGFP, was fused to the carboxyl-terminus of the M-PMV Gag polyprotein, to create a Gag-GFP fusion that could be visualized in live cells. In order to express this fusion protein in the context of an M-PMV proviral backbone, it was necessary to codon-optimize gag, optimize the Kozak sequence preceding the initiating methionine, and mutate an internal methionine codon to one for alanine (M100A) to prevent internal initiation of translation. Co-expression of this pSARM-Gag-GFP-M100A vector with a WT M-PMV provirus resulted in efficient assembly and release of capsids. Results from fixed-cell immunofluorescence and pulse-chase analyses of wild type and mutant Gag-GFP constructs demonstrated comparable intracellular localization and release of capsids to untagged counterparts. Real-time, live-cell visualization and analysis of the GFP-tagged capsids provided strong evidence for a role for microtubules in the intracellular transport of M-PMV capsids. Thus, this M-PMV Gag-GFP vector is a useful tool for identifying novel virus-cell interactions involved in intracellular M-PMV capsid transport in a dynamic, real-time system.

Indexed as

Biological TransportCapsidCell MembraneCell SurvivalFluorescent DyesGene Products, gagGenetic VectorsGreen Fluorescent ProteinsHEK293 CellsHumansKineticsMason-Pfizer monkey virusMicrotubulesMolecular ImagingMovementProtein TransportFluorescent DyesGene Products, gagGreen Fluorescent ProteinsRecombinant Fusion Proteins

Identifiers

PMID24386297
PMCPMC3873405
OpenAlexW2061748602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.